Exact Mass: 647.2294726000001

3-Deoxydihydrostreptomycin 3-phosphate

BGC 945; ONX 0801

N-(4-{[(6s)-2-(Hydroxymethyl)-4-Oxo-4,6,7,8-Tetrahydro-1h-Cyclopenta[g]quinazolin-6-Yl](Prop-2-Yn-1-Yl)amino}benzoyl)-L-gamma-Glutamyl-D-Glutamic Acid

C471 - Enzyme Inhibitor > C2021 - Thymidylate Synthase Inhibitor

N-(4-{[(6s)-2-(Hydroxymethyl)-4-Oxo-4,6,7,8-Tetrahydro-1h-Cyclopenta[g]quinazolin-6-Yl](Prop-2-Yn-1-Yl)amino}benzoyl)-L-gamma-Glutamyl-D-Glutamic Acid

2-({4-carboxy-1-hydroxy-4-[(4-{[4-hydroxy-2-(hydroxymethyl)-6H,7H,8H-cyclopenta[g]quinazolin-6-yl](prop-2-yn-1-yl)amino}phenyl)formamido]butylidene}amino)pentanedioate

Glu Gln Trp Trp

(4S)-4-amino-4-{[(1S)-3-carbamoyl-1-{[(1S)-1-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}-2-(1H-indol-3-yl)ethyl]carbamoyl}propyl]carbamoyl}butanoic acid

Glu Trp Gln Trp

(4S)-4-amino-4-{[(1S)-1-{[(1S)-3-carbamoyl-1-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}propyl]carbamoyl}-2-(1H-indol-3-yl)ethyl]carbamoyl}butanoic acid

Glu Trp Trp Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanamido]-4-carbamoylbutanoic acid

Gln Glu Trp Trp

(4S)-4-[(2S)-2-amino-4-carbamoylbutanamido]-4-{[(1S)-1-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}-2-(1H-indol-3-yl)ethyl]carbamoyl}butanoic acid

Gln Trp Glu Trp

(4S)-4-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-(1H-indol-3-yl)propanamido]-4-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}butanoic acid

Gln Trp Trp Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanamido]pentanedioic acid

Trp Glu Gln Trp

(4S)-4-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-4-{[(1S)-3-carbamoyl-1-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}propyl]carbamoyl}butanoic acid

Trp Glu Trp Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-4-carboxybutanamido]-3-(1H-indol-3-yl)propanamido]-4-carbamoylbutanoic acid

Trp Gln Glu Trp

(4S)-4-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-4-carbamoylbutanamido]-4-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}butanoic acid

Trp Gln Trp Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-4-carbamoylbutanamido]-3-(1H-indol-3-yl)propanamido]pentanedioic acid

Trp Trp Glu Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanamido]-4-carboxybutanamido]-4-carbamoylbutanoic acid

Trp Trp Gln Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanamido]-4-carbamoylbutanamido]pentanedioic acid

C23H37N9O13 (647.2510712000001)

DDNRE

Asp-Asp-Asn-Arg-Glu

Cloperastine fendizoate

C40H38ClNO5 (647.2438367999999)

C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist

Lercanidipine hydrochloride

C36H42ClN3O6 (647.2761982)

C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker

D-ALA2 D-MET5-ENKEPHALIN ACETATE

C30H41N5O9S (647.2624856000001)

sulfosuccinimidyl n-[n-(d-biotinyl)-6-aminohexanoyl]-6-aminohexanoate

C26H41N5O10S2 (647.2294726000001)

(S)-Cloperastine Fendizoate

C20H24ClNO.C20H14O4 (647.2438367999999)

Dihydro-acarbose

C25H45NO18 (647.263651)

N-(4-{[(6s)-2-(Hydroxymethyl)-4-Oxo-4,6,7,8-Tetrahydro-1h-Cyclopenta[g]quinazolin-6-Yl](Prop-2-Yn-1-Yl)amino}benzoyl)-L-gamma-Glutamyl-D-Glutamic Acid

2-({4-carboxy-1-hydroxy-4-[(4-{[4-hydroxy-2-(hydroxymethyl)-6H,7H,8H-cyclopenta[g]quinazolin-6-yl](prop-2-yn-1-yl)amino}phenyl)formamido]butylidene}amino)pentanedioate

(2S)-2-[[(2R)-2-[[(2S)-2-[[(2R)-2-[(2R,3S,4R,5S)-5-acetamido-3-hydroxy-2-(hydroxymethyl)oxan-4-yl]oxypropanoyl]amino]propanoyl]amino]-4-carboxylatobutanoyl]amino]-6-azaniumylheptanedioate

C26H41N5O14-2 (647.2649886)

Dihydrostreptomycin 3alpha-phosphate

C30H37N3O9S2 (647.1971112000001)

N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)sulfonyl-methylamino]methyl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-methoxybenzenesulfonamide

N-(4-{[(6s)-2-(Hydroxymethyl)-4-Oxo-4,6,7,8-Tetrahydro-1h-Cyclopenta[g]quinazolin-6-Yl](Prop-2-Yn-1-Yl)amino}benzoyl)-L-gamma-Glutamyl-D-Glutamic Acid

C38H37N3O7 (647.2631372000001)

C471 - Enzyme Inhibitor > C2021 - Thymidylate Synthase Inhibitor

5'-O-DMT-N4-Bz-5-Me-dC

5'-O-DMT-N4-Bz-5-Me-dC is a modified nucleoside. 5'-O-DMT-2'-O-TBDMS-rI can be used in the synthesis of deoxyribonucleic acid or nucleic acid.

n-[(2r,3r,4r,5s,6r)-2-{[(2s,3r,4r,5r,6s)-2-[(5,7-dihydroxy-9,10-dioxo-4-propylanthracen-2-yl)oxy]-4,5-dihydroxy-6-methyloxan-3-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]ethanimidic acid

C31H37NO14 (647.2213942000001)

(3s,4s)-3-[(2r,3r,4r,5s,6s)-6-[(acetyloxy)methyl]-3,5-dihydroxy-4-{[(2r,4r,5r,6r)-5-hydroxy-4-methoxy-6-methyl-5-[(1r)-1-[(2-methylpropanoyl)oxy]ethyl]oxan-2-yl]oxy}oxan-2-yl]-2,4-dihydroxy-6-imino-5-oxocyclohex-1-ene-1-carboxylic acid

(3s,4s)-3-[(2r,3r,4r,5s,6s)-6-[(acetyloxy)methyl]-3,5-dihydroxy-4-{[(2r,4r,5r,6r)-5-hydroxy-4-methoxy-6-methyl-5-[(1r)-1-[(2-methylpropanoyl)oxy]ethyl]oxan-2-yl]oxy}oxan-2-yl]-2,4-dihydroxy-6-imino-5-oxocyclohex-1-ene-1-carboxylic acid

3-{6-[(acetyloxy)methyl]-3,5-dihydroxy-4-[(5-hydroxy-4-methoxy-6-methyl-5-{1-[(2-methylpropanoyl)oxy]ethyl}oxan-2-yl)oxy]oxan-2-yl}-2,3-dihydroxy-6-imino-5-oxocyclohex-1-ene-1-carboxylic acid

(3s)-3-[(2s,3s,4r,5r,6s)-6-[(acetyloxy)methyl]-3,5-dihydroxy-4-{[(2r,4s,5s,6s)-5-hydroxy-4-methoxy-6-methyl-5-[(1s)-1-[(2-methylpropanoyl)oxy]ethyl]oxan-2-yl]oxy}oxan-2-yl]-2,3-dihydroxy-6-imino-5-oxocyclohex-1-ene-1-carboxylic acid

(3s)-3-[(2s,3s,4r,5r,6s)-6-[(acetyloxy)methyl]-3,5-dihydroxy-4-{[(2r,4s,5s,6s)-5-hydroxy-4-methoxy-6-methyl-5-[(1s)-1-[(2-methylpropanoyl)oxy]ethyl]oxan-2-yl]oxy}oxan-2-yl]-2,3-dihydroxy-6-imino-5-oxocyclohex-1-ene-1-carboxylic acid

[(2s,3s,4r,5s)-5-{[(1r,2s,3r,4r,5s,6r)-2,4-dicarbamimidamido-3,5,6-trihydroxycyclohexyl]oxy}-4-{[(2s,3s,4s,5r,6s)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy}-2-methyloxolan-3-yl]methoxyphosphonic acid

[(2s,3s,4r,5s)-5-{[(1r,2s,3r,4r,5s,6r)-2,4-dicarbamimidamido-3,5,6-trihydroxycyclohexyl]oxy}-4-{[(2s,3s,4s,5r,6s)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy}-2-methyloxolan-3-yl]methoxyphosphonic acid

(5s)-5-[(2s,3s,4r,5r,6s)-6-[(acetyloxy)methyl]-3,5-dihydroxy-4-{[(2r,4s,5s,6s)-5-hydroxy-4-methoxy-6-methyl-5-[(1s)-1-[(2-methylpropanoyl)oxy]ethyl]oxan-2-yl]oxy}oxan-2-yl]-2-amino-5-hydroxy-3,6-dioxocyclohex-1-ene-1-carboxylic acid

(5s)-5-[(2s,3s,4r,5r,6s)-6-[(acetyloxy)methyl]-3,5-dihydroxy-4-{[(2r,4s,5s,6s)-5-hydroxy-4-methoxy-6-methyl-5-[(1s)-1-[(2-methylpropanoyl)oxy]ethyl]oxan-2-yl]oxy}oxan-2-yl]-2-amino-5-hydroxy-3,6-dioxocyclohex-1-ene-1-carboxylic acid

C31H37NO14 (647.2213942000001)

n-[2-({2-[(5,7-dihydroxy-9,10-dioxo-4-propylanthracen-2-yl)oxy]-4,5-dihydroxy-6-methyloxan-3-yl}oxy)-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]ethanimidic acid

1-{4-[(1e,3e)-4-{[(1s)-1-carboxy-3-(c-hydroxycarbonimidoyl)propyl]-c-hydroxycarbonimidoyl}buta-1,3-dien-1-yl]phenyl}-2-[4-(5-{[(1s)-1-carboxy-3-(c-hydroxycarbonimidoyl)propyl]amino}-5-hydroxypenta-2,4-dien-1-ylidene)cyclohexa-2,5-dien-1-ylidene]-1-oxohydrazinium

1-{4-[(1e,3e)-4-{[(1s)-1-carboxy-3-(c-hydroxycarbonimidoyl)propyl]-c-hydroxycarbonimidoyl}buta-1,3-dien-1-yl]phenyl}-2-[4-(5-{[(1s)-1-carboxy-3-(c-hydroxycarbonimidoyl)propyl]amino}-5-hydroxypenta-2,4-dien-1-ylidene)cyclohexa-2,5-dien-1-ylidene]-1-oxohydrazinium

[C32H35N6O9]+ (647.24654)

5-{6-[(acetyloxy)methyl]-3,5-dihydroxy-4-[(4-hydroxy-5-methoxy-3-methyl-4-{1-[(2-methylpropanoyl)oxy]ethyl}oxan-2-yl)oxy]oxan-2-yl}-2-amino-5-hydroxy-3,6-dioxocyclohex-1-ene-1-carboxylic acid